The company is addressing one of society’s most challenging issues; meeting the growing demand for quality healthcare while mitigating the ever increasing cost to provide the care. Time for Medicine has developed a platform for providing remote diagnostics for many outpatient demands. This “telehealth” platform is a combination of web, mobile and cloud technology to facilitate interaction between clinical consultants with patients, thus reducing time and cost for both provider and recipient. Remote diagnosis and management of certain chronic conditions can completely alter the cost paradigm of today’s health care system.
Leads investors, including Nadia Crandall of theHarvard Business School of Angels of London, have already contributed £100,000. The platform they have developed is expected to save NHS hundreds of millions annually. It will also be made available for private clients. Contracts have already been signed with multiple pharmacists and super markets to aid in providing their services.
About Time for Medicine has stated their goal must be to provide the highest quality care and approach:
- All company activity must be of the highest possible ethical standard
- Patient concerns come before financial concerns
- Medicine practiced at the highest level is behind everything they do
Time for Medicine is managed by Clive Minihan who previously held senior management positions at the Burton Group and BP. During the last 12 years Minihan has been involved in multiple successful startups having generated significant returns for investors.
Time for Medicine is offering 8.05% equity with a pre-money valuation of £3,426,708 and stands at 43% funded as of today.
Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!